Unadjusted analysis included year, age, sex, race/ethnicity, comorbidities, rupture status, hospital teaching status, and emergency status. Multivariable analysis was stratified by year for any PSI in EVAR vs OAR. Postoperative mortality was analyzed to control for the overall safety.
1 During this period of adoption, the Society for Vascular Surgery reported an overall decline in aneurysm-related deaths after repair of intact or ruptured AAA. 4 Randomized clinical trials have shown that EVAR reduces length of stay and postoperative complications. [5] [6] [7] [8] [9] [10] However, the effects of rapid adoption on patient safety have not been formally evaluated within existing regulatory frameworks, an important aspect of surgical care to the patient consumer and to health care systems. In 2003, the Agency for Healthcare Research and Quality (AHRQ) 11 established Patient Safety Indicators (PSIs) to standardize monitoring of preventable adverse events during hospitalizations in the United States. In contrast to traditional surgical complications, these quality measures capture adverse events that result from exposure to the health care system itself. Patient Safety Indicators were developed by expert consensus, were validated with empirical analysis, and were shown to have greater specificity and less bias than other measures. [12] [13] [14] They are widely endorsed and used by agencies monitoring quality in cases such as the National Quality Forum and the Centers for Medicare and Medicaid Services' Hospital Compare Program. 15 Multiple PSIs were designed specifically for surgery but have only recently been used to evaluate the dissemination of innovative technology. 16, 17 The evidence base driving the popularity of EVAR did not include comparative evaluation of PSIs after open and endovascular AAA repair. This is true in large part because PSIs were not introduced until 2003. However, recent literature shows higher rates of PSIs after vascular surgery and usefulness in monitoring PSIs after surgery for peripheral vascular disease and unruptured cerebral aneurysm repair. [18] [19] [20] This study evaluates the comparative safety of endovascular over open AAA repair by measuring PSIs associated with each procedure over time.
Methods
Data from 2003 to 2010 were extracted from the Nationwide Inpatient Sample (NIS). 21 The NIS is a public deidentified da- In total, 4383 PSIs were documented during the study period ( Table 1 ). The total number of PSIs annually declined from 641 (7.4%) in 2003 to 377 (4.4%) in 2010. Patients undergoing EVAR were less likely to have any PSI (3.0%) compared with patients undergoing OAR (11.2%). Specifically, patients undergoing EVAR were less likely than those undergoing OAR to experience the following: failure to rescue (12.2% vs 19.9%), iatrogenic pneumothorax (0.1% vs 0.2%), central venous catheter-related bloodstream infection (0.2% vs 1.1%), postoperative hemorrhage (0.4% vs 1.4%), postoperative physiological or metabolic derangement (0.3% vs 1.4%), postoperative respiratory failure (3.3% vs 14.0%), postoperative pulmonary embolism or deep vein thrombosis (0.5% vs 2.0%), postoperative sepsis (3.0% vs 3.8%), and accidental puncture or laceration (1.1% vs 3.0%) ( Table 2) . No significant differences between EVAR and OAR were observed for the following PSIs: decubitus ulcer, postoperative hip fracture, postoperative wound dehiscence, or transfusion reaction. Aortic aneurysm repairs do not qualify for the category of death in low-mortality diagnosis related groups, and it is included herein only for completeness. The low denominator for postoperative respiratory failure is also owing to strict inclusion and exclusion criteria, available in the AHRQ technical specifications. In total, 3717 deaths were documented during the study period. Patients were less likely to die after EVAR (1.8%) than after OAR (10.6%) ( Table 1 ). The risk-adjusted odds of dying after EVAR were 72.3% less than after OAR (OR, 0.28; 95% CI, 0.24-0.32). When stratified by year with OAR as the reference group, the odds of death with EVAR were comparatively less for every year studied ( Understanding the dynamics of surgical evolution is key to the study of patient safety. Our retrospective review confirms that the safety of AAA repair improved nationwide with the adoption of EVAR. However, the driving factors making EVAR safer in some years compared with others are unclear. Variation in performance with EVAR may correlate with changes in practice patterns such as adaptations of EVAR devices (ie, percutaneous techniques) or expansion of indications to new patient cohorts (ie, emergency cases). Although beyond the scope of this study, changes in performance over time merit further investigation. The adoption of laparoscopic partial nephrectomy, laparoscopic radical nephrectomy, and laparoscopic colectomies represents the greatest reduction in PSIs after passing a critical "tipping point." 16, 17, 23 Theoretically, the tipping point corresponds to a transition as early adopters master the skill set of innovators.
24,25 In prac- tice, these factors remain elusive and understudied. Future studies could benefit from the standardized PSI algorithms to monitor trends in safety over time and to promote the adoption of the safest techniques. This study also provides an opportunity to consider the appropriate pace and scope of adoption in relation to randomized clinical trials. Timing was especially relevant in the context of robotics-assisted radical prostatectomy, 26 whereby the adoption proceeded to 28% before the first large outcomes study, 27 which documented an increased risk of perioperative patient safety events. Rapid dissemination of novel technologies without a foundation of level 1 evidence creates the potential for large-scale disappointment and public harm.
28-30
This contrasts with the experience of laparoscopic colectomy, whereby the results of randomized clinical trials were available before the proportion of laparoscopic techniques ex- ceeded 10% of all colectomies. 16 In the case of EVAR, our study captures the period when publications from multiple randomized clinical trials were published. 5-10 When level 1 data became available, EVAR already constituted 50% of all AAA repairs nationwide. However, unlike robotics-assisted prostatectomy, the overall number of AAA repairs did not increase during the adoption of EVAR (Figure 1 ). This is likely the result of strong indications from the United Kingdom Small Aneurysm Trial 31 and the Aneurysm Detection and Management Veterans Affairs Cooperative Study, 32 which showed no benefit for repair of AAAs less than 5.5 cm in diameter. The appropriate pace of dissemination remains unknown but would ideally strike a balance between the benefits of new expertise and the cost of the learning curve, while maintaining clear indications for surgery. The use of PSIs to monitor the safety of innovative technologies carries significant policy implications as well. As hospital performance is increasingly scrutinized, bundled reimbursement plans will favor surgical procedures that add value instead of volume. It is also true that high-level health system infrastructure and financing affect the likelihood of PSI occurrence over time. 33 Clement et al 33 showed that changes to the reimbursement climate altered occurrence rates in 11 states for select PSIs between 1995 and 2000. Although we do not evaluate systems-level factors herein, standardized metrics to ensure safe delivery of care will be a vital component of quality control as the era of accountable care organizations matures. This crucial component of the future clinical research agenda will allow academic surgeons to have a strong role in producing research that encourages self-regulation and autonomy in the United States health care system. This study has several inherent limitations that stem from the use of administrative databases. While discharge data sets standardize diagnosis codes (ie, ICD-9), no verification process validates that the codes are used correctly. The ICD-9 codes can represent a broad range of problems, with variation between hospitals, whereby coding is known to be inconsistent. 34, 35 Our analysis limits this type of coding bias by linking AAA diagnosis to EVAR and OAR procedure codes, which are subject to more oversight because they are frequently tied to billing and reimbursement. 36 It is also likely that coding errors are distributed evenly across the database, minimizing quantitative differences in outcomes. Herein, we validated our PSI results by reporting inpatient mortality because it is less ambiguous than other diagnoses. Notably, our mortality after OAR (10.6%) is significantly greater than the mortality after OAR in randomized clinical trials 5-10 (approximately 4%), which may reflect our inclusion of emergency and ruptured cases. This also points to a relative strength of administrative data sets because we show general population results in real-world settings, whereas performance in clinical trials 5-10 may be artificial in that patients and surgeons are rigorously preselected. However, standardized quality indicators rooted in administrative databases are not intended to replace randomized clinical trials, which are better suited to monitor traditional postoperative complications. Another weakness lies in the timing of this study in relation to the adoption of EVAR. Since its introduction in 1991, EVAR has been noted to follow the standard gaussian pattern of dissemination of technology.
2 Studies 37,38 of adoption describe 5 stages that correspond to their relationship (in standard deviations) to the mean time of adoption: innovators (>2 SD from the mean), early adopters (1-2 SD), early and late majority (±1 SD), and laggards (>1 SD behind the mean). 
Conclusions
In summary, EVAR technology is increasingly the preferred method for AAA repair, and this study is the first to date to report PSIs as indicators of the comparative safety of EVAR over OAR in the context of rapid EVAR adoption. Using PSIs as a surrogate for the comparative safety, EVAR was safer than OAR every year and failed to achieve statistical significance only in 2007. In addition, EVAR became safer during the study period, and this finding was validated with corresponding declines in mortality. The volume and safety of open repair remained unchanged. Future monitoring is necessary to identify the driving factors of improvements in safety along the adoption curve. In showing that EVAR is safer than OAR, these results confirm the findings of multiple randomized clinical trials published during the study period and imply a role for PSIs and administrative databases in evaluating the safety of emerging technologies. In addition, this study adds to the evidence that the adoption of minimally invasive surgical techniques improved the overall safety of AAA repairs nationwide. 
